5 Digital Life Science Trends, Gilead Pays $567M for Cell Design Labs, Samsung Biologics Second Plant EMA-approved and More...
 Trouble viewing this email? Read it online
Follow us on:       
Sponsored by Jubilant
December 13, 2017
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites
Sponsored by Thermo Fisher

FEATURED NEWS
Expert's Opinion: Five Digital Trends Transforming the Life Sciences Industry
Putting patients at the heart of innovation
Read More >>

Gilead to Acquire Cell Design Labs in $567M Transaction
Expands focus on CAR-T drugs with technology platform and pipeline
Read More >>

Compliance with New USP Regulations on Elemental Impurities
USP <232> and <233> go into effect soon. With high sensitivity, low running costs, and easy-to-use software, Shimadzu ICP mass spectrometer is the optimum solution for analysis of toxic elements.
Learn More >>

LATEST STORIES
Samsung BioLogics Receives EMA Approval for its Second Plant
Licensed by EMA for its second plant only two months after FDA approval
Read More >>

Video: Abzena Enters ADC Master Services Agreement
The contract has a potential value of $5 million
Read More >>

CMC Bio, Harpoon Therapeutics Partner for Cancer Treatment
The manufacturing and development agreement involves three TriTAC molecules
Read More >>

Halo Pharma Offers Range of FDC Drug Products
Halo-produced FDC drugs already approved and in development benefit patients and reduce costs
Read More >>

PharmaForce Expands Two Facilities
The investment will add over 140,000 square feet to the company's production space
Read More >>

Supply Chain Wizard to Oversee Massive Serialization Project
The program will allow Nordic Group to achieve higher efficiency and productivity
Read More >>

WDSrx Adds NJ Facility
63,500 sq.-ft. facility in South Brunswick, NJ brings total space to 320,000 sq.-ft.
Read More >>

SGS Launches New Large Molecule Bioanalytical Services
8,400-square meter lab includes the installation of Sciex instruments
Read More >>

   

CURRENT ISSUE
November/December 2017



Microsite Spotlight

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials.



We hope you enjoyed this edition of Contract Pharma Direct's Breaking News

You are receiving this message because you opted in at contractpharma.com. To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address (cp@email.contractpharma.com) to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
70 Hilltop Road, Ramsey, NJ 07446 USA
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2017 Contract Pharma All rights reserved.